Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
SARS-CoV-2 vaccination creates a strong, persistent T-cell response
St. Jude Immunology study details how T cells respond to mRNA vaccination for SARS-CoV-2. Published in Cell, in collaboration with Washington University St. Louis.
-
Research reveals features that influence phase separation
St. Jude researchers reveal more details of processes cells use to organize the proteins within them, which may provide insight into neurological diseases and cancer.
-
Chromatin architecture reveals vulnerabilities to neurodegenerative movement disorders
St. Jude researchers showed why neurons called Purkinje cells in the cerebellum are particularly susceptible to DNA damage that goes unrepaired.
-
Phase separation underlies leukemia caused by NUP98 fusion oncoproteins
St. Jude scientists describe how a group of well-known fusion oncoproteins causes leukemia in the journal Cancer Discovery.
-
World Health Organization and St. Jude Children’s Research Hospital to dramatically increase global access to childhood cancer medicines
WHO and St. Jude will establish a platform to dramatically increase access to childhood cancer medicines in low- and middle-income countries
-
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
St. Jude phase II clinical trial results suggest monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.